DOD
Search
Discussions
Biomedical Jobmarket
News
DOD Alert
Edit DOD
 
ACCOUNT
Login
Register
Forgotten Password?
 
 
Enteroinsular Axis
 
Diabetes OD > Disease Management > T2DM > Metabolic Control > Anti-Hyperglycemic and Anti-Apoptotic Agents > Incretin Hormones > GLP-1 > Enteroinsular Axis

Enteroinsular Axis

(Journal Article): Gut glucagon, enteroglucagon, gut glucagonlike immunoreactivity, glicentin - current status.
 
Holst JJ
 
IN: Gastroenterology 1983; 84(6):1602-1613
Impact Factor(s) of Gastroenterology: 13.092 (2004), 12.718 (2003), 13.44 (2002), 13.02 (2001)

ABSTRACT: Glucagonlike substances in extracts of intestinal mucosa were already described in 1948 by Sutherland and deDuve (1), who used a bioassay technique for the identification. After th... Click HERE for details

 


(Journal Article): Glucagon-like peptide-1, a new hormone of the entero-insular axis.
 
0rskov C
 
IN: Diabetologia 1992; 35(8):701-711
Impact Factor(s) of Diabetologia: 5.583 (2004), 5.689 (2003), 5.136 (2002), 6.299 (2001)

ABSTRACT: The post-translational processing of proglucagon in the small intestine gives rise to glucagon-like peptide-1 (PG 78-107 amide) which has profound effects on the endocrine pancreas... Click HERE for details

 

(Journal Article): Effect of truncated glucagon-like peptide-1 [proglucagon-(78-107) amide] on endocrine secretion from pig pancreas, antrum, and nonantral stomach.
 
0rskov C, Holst JJ, Nielsen OV
 
IN: Endocrinology 1988; 123(4):2009-2013
Impact Factor(s) of Endocrinology: 5.151 (2004), 5.063 (2003), 5.095 (2002), 4.971 (2001)

ABSTRACT: We studied the effect of truncated glucagon-like peptide-1 [naturally occurring GLP-1; proglucagon-(78-107) amide], a potent insulinotropic peptide from the pig ileum, on endocrine... Click HERE for details

 



 
Contribute to this subject area!